Trial Profile
A efficacy trial of denosumab in patients with primary hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Hyperparathyroidism
- Focus Therapeutic Use
- 12 Dec 2015 New trial record